TSX Venture Exchange symbol: IBR
VANCOUVER, Aug. 23 /CNW/ - The Board of Directors of International Bio
Recovery Corporation ("IBR") (TSX-V:IBR) is pleased to announce the
appointment of Henry J. Bow as interim President and Chief Executive Officer
of the Company.
IBR is focusing on building plant capacity in North America, moving
forward on recent R&D breakthroughs and creating market demand for its end
Mr. Bow will play an integral role in these developments. Mr. Bow will be
responsible for overseeing all facets of the Company's operations and will
report to the Board of Directors. He has been serving as Vice President of the
Mr. Bow has a wealth of experience in all facets of business with an
extensive background in finance, operations and marketing as well as strategic
planning and organizational development.
Located in North Vancouver, BC, IBR markets its technology products
through the sale of licenses. The Company's current and medium term focus is
to further develop its marketing capacity to enhance technology license sales.
The Company is committed to research and development to continue to improve
the efficiency of its technology and the quality of Genica branded fertility
products. It is further committed to developing a world wide marketing
capability to ensure market acceptance of the fertility products.
THE TSX VENTURE EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY
OR THE ACCURACY OF THIS RELEASE.
For further information:
For further information: Ben Van Dyk, Chairman of the Board, IBR, (604)
924-1023 ext 304, (604) 924-1043 fax, email@example.com; Henry J. Bow,
President & CEO, IBR, (604) 924-1023 ext 309, (604) 924-1043 fax,